The Journal of Dermatology, ISSN 0385-2407, 05/2018, Volume 45, Issue 5, pp. 606 - 608
We report a 9‐year‐old Japanese female patient with atopic dermatitis associated with idiopathic thrombocytopenic purpura. She demonstrated high serum...
idiopathic thrombocytopenic purpura | atopic dermatitis | platelet | thymus and activation‐regulated chemokine | biomarker | thymus and activation-regulated chemokine | DISEASES | PLATELETS | TARC | DERMATOLOGY | Thrombocytopenic purpura | Atopic dermatitis | Development and progression | Allergens | Purpura | Immunoglobulin E | Idiopathic thrombocytopenic purpura | Dermatitis | Chemokines | Thymus
idiopathic thrombocytopenic purpura | atopic dermatitis | platelet | thymus and activation‐regulated chemokine | biomarker | thymus and activation-regulated chemokine | DISEASES | PLATELETS | TARC | DERMATOLOGY | Thrombocytopenic purpura | Atopic dermatitis | Development and progression | Allergens | Purpura | Immunoglobulin E | Idiopathic thrombocytopenic purpura | Dermatitis | Chemokines | Thymus
Journal Article
Nature Immunology, ISSN 1529-2908, 01/2017, Volume 18, Issue 1, pp. 64 - 73
Atopic dermatitis is increasing worldwide in correlation with air pollution. Various organic components of pollutants activate the transcription factor AhR...
ITCH | DISEASES | PRURITUS | TRANSCRIPTION | ULTRAFINE PARTICLES | SKIN | IMMUNOLOGY | EXPRESSION | SENSORY NEURONS | THYMIC STROMAL LYMPHOPOIETIN | NC/NGA MICE | Humans | Basic Helix-Loop-Helix Transcription Factors - metabolism | Dermatitis, Atopic - immunology | Receptors, Aryl Hydrocarbon - metabolism | Axon Guidance - genetics | Epidermis - innervation | Pruritus - immunology | Animals, Newborn | Epidermis - pathology | Basic Helix-Loop-Helix Transcription Factors - genetics | Mice, Inbred C57BL | Cells, Cultured | Gene Expression Regulation | Receptors, Aryl Hydrocarbon - genetics | Receptor, EphB2 - genetics | Receptor, EphB2 - metabolism | Nerve Tissue Proteins - genetics | Keratin-15 - metabolism | Mice, Knockout | Nerve Tissue Proteins - metabolism | Animals | Air Pollutants - adverse effects | Mice | Keratin-15 - genetics | Keratinocytes - physiology | Atopic dermatitis | Aromatic compounds | Physiological aspects | Air pollution | Research | Health aspects | Risk factors
ITCH | DISEASES | PRURITUS | TRANSCRIPTION | ULTRAFINE PARTICLES | SKIN | IMMUNOLOGY | EXPRESSION | SENSORY NEURONS | THYMIC STROMAL LYMPHOPOIETIN | NC/NGA MICE | Humans | Basic Helix-Loop-Helix Transcription Factors - metabolism | Dermatitis, Atopic - immunology | Receptors, Aryl Hydrocarbon - metabolism | Axon Guidance - genetics | Epidermis - innervation | Pruritus - immunology | Animals, Newborn | Epidermis - pathology | Basic Helix-Loop-Helix Transcription Factors - genetics | Mice, Inbred C57BL | Cells, Cultured | Gene Expression Regulation | Receptors, Aryl Hydrocarbon - genetics | Receptor, EphB2 - genetics | Receptor, EphB2 - metabolism | Nerve Tissue Proteins - genetics | Keratin-15 - metabolism | Mice, Knockout | Nerve Tissue Proteins - metabolism | Animals | Air Pollutants - adverse effects | Mice | Keratin-15 - genetics | Keratinocytes - physiology | Atopic dermatitis | Aromatic compounds | Physiological aspects | Air pollution | Research | Health aspects | Risk factors
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2005, Volume 353, Issue 20, pp. 2135 - 2147
A genomic study of four groups of melanoma arising at sites with different levels of exposure to ultraviolet light reveals distinct genetic alterations among...
MEDICINE, GENERAL & INTERNAL | BRAF MUTATIONS | CUTANEOUS MELANOMA | TUMOR | RISK | MALIGNANT-MELANOMA | SEVERE SUNBURN | SKIN | MICROARRAYS | COMPARATIVE GENOMIC HYBRIDIZATION | NEVI | Cyclin-Dependent Kinase 4 - genetics | Humans | Middle Aged | Male | Phosphatidylinositol 3-Kinases - metabolism | Melanoma - genetics | Aged, 80 and over | Adult | Female | DNA, Neoplasm - analysis | Melanoma - metabolism | PTEN Phosphohydrolase - genetics | Nucleic Acid Hybridization | Signal Transduction | Risk Factors | PTEN Phosphohydrolase - metabolism | Ultraviolet Rays - adverse effects | Skin Neoplasms - metabolism | Environmental Exposure - adverse effects | Cyclin D1 - genetics | Proto-Oncogene Proteins B-raf - genetics | Skin Neoplasms - genetics | Aged | Mutation | Genes, ras | Genome, Human | Mitogen-Activated Protein Kinases - metabolism | Genetic aspects | Research | Melanoma | Cancer | Ultraviolet radiation | Heredity | Genetic diversity | Health risk assessment | Skin cancer
MEDICINE, GENERAL & INTERNAL | BRAF MUTATIONS | CUTANEOUS MELANOMA | TUMOR | RISK | MALIGNANT-MELANOMA | SEVERE SUNBURN | SKIN | MICROARRAYS | COMPARATIVE GENOMIC HYBRIDIZATION | NEVI | Cyclin-Dependent Kinase 4 - genetics | Humans | Middle Aged | Male | Phosphatidylinositol 3-Kinases - metabolism | Melanoma - genetics | Aged, 80 and over | Adult | Female | DNA, Neoplasm - analysis | Melanoma - metabolism | PTEN Phosphohydrolase - genetics | Nucleic Acid Hybridization | Signal Transduction | Risk Factors | PTEN Phosphohydrolase - metabolism | Ultraviolet Rays - adverse effects | Skin Neoplasms - metabolism | Environmental Exposure - adverse effects | Cyclin D1 - genetics | Proto-Oncogene Proteins B-raf - genetics | Skin Neoplasms - genetics | Aged | Mutation | Genes, ras | Genome, Human | Mitogen-Activated Protein Kinases - metabolism | Genetic aspects | Research | Melanoma | Cancer | Ultraviolet radiation | Heredity | Genetic diversity | Health risk assessment | Skin cancer
Journal Article
Infection and Immunity, ISSN 0019-9567, 12/2005, Volume 73, Issue 12, pp. 7967 - 7976
Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
INFECTIOUS DISEASES | HUMAN MONOCYTIC CELLS | LIPOTEICHOIC ACID | MURAMYL DIPEPTIDE | HOST RECOGNITION | WALL COMPONENTS | IFN-GAMMA | ADJUVANT ACTIVITY | DIAMINOPIMELIC ACID | IMMUNOLOGY | BACTERIAL PEPTIDOGLYCAN | CUTTING EDGE | Adjuvants, Immunologic - pharmacology | Diaminopimelic Acid - pharmacology | Dendritic Cells - immunology | Humans | RNA, Messenger - analysis | Intracellular Signaling Peptides and Proteins - metabolism | RNA, Messenger - metabolism | Th1 Cells - immunology | Th1 Cells - metabolism | Dendritic Cells - drug effects | Toll-Like Receptors - metabolism | Intracellular Signaling Peptides and Proteins - genetics | Polylysine - pharmacology | Poly I-C - pharmacology | Cytokines - metabolism | Interleukin-12 - metabolism | Nod2 Signaling Adaptor Protein | Adaptor Proteins, Signal Transducing - agonists | Toll-Like Receptors - agonists | Acetylmuramyl-Alanyl-Isoglutamine - pharmacology | Drug Synergism | Diaminopimelic Acid - analogs & derivatives | Intracellular Signaling Peptides and Proteins - agonists | Toll-Like Receptors - genetics | Adaptor Proteins, Signal Transducing - genetics | Lipid A - pharmacology | Nod1 Signaling Adaptor Protein | Adaptor Proteins, Signal Transducing - metabolism | Oligodeoxyribonucleotides - pharmacology | Oligopeptides - pharmacology | Host Response and Inflammation
INFECTIOUS DISEASES | HUMAN MONOCYTIC CELLS | LIPOTEICHOIC ACID | MURAMYL DIPEPTIDE | HOST RECOGNITION | WALL COMPONENTS | IFN-GAMMA | ADJUVANT ACTIVITY | DIAMINOPIMELIC ACID | IMMUNOLOGY | BACTERIAL PEPTIDOGLYCAN | CUTTING EDGE | Adjuvants, Immunologic - pharmacology | Diaminopimelic Acid - pharmacology | Dendritic Cells - immunology | Humans | RNA, Messenger - analysis | Intracellular Signaling Peptides and Proteins - metabolism | RNA, Messenger - metabolism | Th1 Cells - immunology | Th1 Cells - metabolism | Dendritic Cells - drug effects | Toll-Like Receptors - metabolism | Intracellular Signaling Peptides and Proteins - genetics | Polylysine - pharmacology | Poly I-C - pharmacology | Cytokines - metabolism | Interleukin-12 - metabolism | Nod2 Signaling Adaptor Protein | Adaptor Proteins, Signal Transducing - agonists | Toll-Like Receptors - agonists | Acetylmuramyl-Alanyl-Isoglutamine - pharmacology | Drug Synergism | Diaminopimelic Acid - analogs & derivatives | Intracellular Signaling Peptides and Proteins - agonists | Toll-Like Receptors - genetics | Adaptor Proteins, Signal Transducing - genetics | Lipid A - pharmacology | Nod1 Signaling Adaptor Protein | Adaptor Proteins, Signal Transducing - metabolism | Oligodeoxyribonucleotides - pharmacology | Oligopeptides - pharmacology | Host Response and Inflammation
Journal Article
Journal of Dermatological Science, ISSN 0923-1811, 2007, Volume 49, Issue 3, pp. 187 - 194
Summary Skin undergoes self-renewal throughout life. Terminally differentiated keratinocytes, namely the corneocytes, are continually shed from the surface of...
Dermatology | Keratinocyte | Oncogenesis | Psoriasis | Differentiation | Notch | Cross-talk | STEM-CELLS | differentiation | DROSOPHILA MASTERMIND | CANCER CELLS | cross-talk | CELL-FATE | P53 HOMOLOG | DERMATOLOGY | GENE | keratinocyte | PATHWAY | psoriasis | oncogenesis | TUMOR-SUPPRESSOR | HUMAN HOMOLOG | Skin Diseases - etiology | Skin - cytology | Animals | Cell Proliferation | Humans | Langerhans Cells - physiology | Homeostasis | Receptors, Notch - physiology | Signal Transduction - physiology | Cell Differentiation | Melanocytes - physiology | Squamous cell carcinoma | Formulae, receipts, prescriptions | Melanoma | Dermatologic agents | Skin | Tumor proteins | Skin cancer
Dermatology | Keratinocyte | Oncogenesis | Psoriasis | Differentiation | Notch | Cross-talk | STEM-CELLS | differentiation | DROSOPHILA MASTERMIND | CANCER CELLS | cross-talk | CELL-FATE | P53 HOMOLOG | DERMATOLOGY | GENE | keratinocyte | PATHWAY | psoriasis | oncogenesis | TUMOR-SUPPRESSOR | HUMAN HOMOLOG | Skin Diseases - etiology | Skin - cytology | Animals | Cell Proliferation | Humans | Langerhans Cells - physiology | Homeostasis | Receptors, Notch - physiology | Signal Transduction - physiology | Cell Differentiation | Melanocytes - physiology | Squamous cell carcinoma | Formulae, receipts, prescriptions | Melanoma | Dermatologic agents | Skin | Tumor proteins | Skin cancer
Journal Article
The Journal of Dermatology, ISSN 0385-2407, 06/2019, Volume 46, Issue 6, pp. e208 - e209
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 10/2015, Volume 135, Issue 10, pp. 2547 - 2550
BREAST-CANCER PATIENTS | REGULATORY T-CELLS | RANKL | DERMATOLOGY | Immunohistochemistry | T-Lymphocytes, Regulatory - metabolism | RANK Ligand - metabolism | Enzyme-Linked Immunosorbent Assay | Humans | Cells, Cultured | Real-Time Polymerase Chain Reaction - methods | Cell Communication - physiology | NF-kappa B - metabolism | Reference Values | Keratinocytes - cytology | Macrophages - cytology | RNA, Messenger - metabolism | Macrophages - metabolism | Matrix Metalloproteinase 7 - metabolism | Keratinocytes - metabolism | Paget Disease, Extramammary - pathology | Paget Disease, Extramammary - genetics | T-Lymphocytes, Regulatory - cytology | Biomarkers, Tumor - metabolism | Biopsy, Needle
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 3853 - 7
Melanoma is an aggressive skin cancer that originates from melanocytes and, especially in the case of early-stage melanoma, is distributed adjacent to the...
MULTIDISCIPLINARY SCIENCES | SKIN | Temperature requirements | Invasiveness | Nevus | Melanoma | Dermis | Melanocytes | Epidermis | Heat conductivity | Lymph nodes | Skin cancer | Biopsy | Skin diseases | Tumors
MULTIDISCIPLINARY SCIENCES | SKIN | Temperature requirements | Invasiveness | Nevus | Melanoma | Dermis | Melanocytes | Epidermis | Heat conductivity | Lymph nodes | Skin cancer | Biopsy | Skin diseases | Tumors
Journal Article
Journal of Dermatological Science, ISSN 0923-1811, 2016, Volume 83, Issue 3, pp. 167 - 173
Abstract Immunosuppressive tumor-associated macrophages (TAMs) promote an immunosuppressive environment in the tumor-bearing host, together with regulatory T...
Dermatology | Immunosuppression | Angiogenetic factors | M2 polarization | Regulatory t cells | Tumor-associated macrophages | Chemokines | CANCER-RELATED INFLAMMATION | MYCOSIS-FUNGOIDES | T-CELL LYMPHOMA | DERMATOLOGY | BREAST-CANCER | GROWTH | RECEPTOR ACTIVATOR | THERAPEUTIC TARGETS | SUPPRESSOR-CELLS | ALTERNATIVE ACTIVATION | PROGRESSION | T-Lymphocytes, Regulatory - metabolism | Skin - metabolism | Humans | Tumor Microenvironment | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Th1 Cells - immunology | T-Lymphocytes, Regulatory - immunology | Th1 Cells - metabolism | Lymphocytes, Tumor-Infiltrating - metabolism | Macrophages - immunology | Skin - pathology | Skin - immunology | Melanoma - metabolism | Skin Neoplasms - pathology | Macrophages - pathology | Signal Transduction | Skin Neoplasms - immunology | Cell Communication | Melanoma - pathology | Skin Neoplasms - metabolism | Macrophages - metabolism | Phenotype | Animals | Melanoma - immunology | Macrophages - drug effects | Chemokines - metabolism | Angiogenic Proteins - metabolism | Skin - drug effects | Immunologic Factors - therapeutic use | Lymphocytes, Tumor-Infiltrating - immunology | Medical colleges | Immunotherapy | Melanoma | Skin | T cells | Macrophages | Skin cancer
Dermatology | Immunosuppression | Angiogenetic factors | M2 polarization | Regulatory t cells | Tumor-associated macrophages | Chemokines | CANCER-RELATED INFLAMMATION | MYCOSIS-FUNGOIDES | T-CELL LYMPHOMA | DERMATOLOGY | BREAST-CANCER | GROWTH | RECEPTOR ACTIVATOR | THERAPEUTIC TARGETS | SUPPRESSOR-CELLS | ALTERNATIVE ACTIVATION | PROGRESSION | T-Lymphocytes, Regulatory - metabolism | Skin - metabolism | Humans | Tumor Microenvironment | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Th1 Cells - immunology | T-Lymphocytes, Regulatory - immunology | Th1 Cells - metabolism | Lymphocytes, Tumor-Infiltrating - metabolism | Macrophages - immunology | Skin - pathology | Skin - immunology | Melanoma - metabolism | Skin Neoplasms - pathology | Macrophages - pathology | Signal Transduction | Skin Neoplasms - immunology | Cell Communication | Melanoma - pathology | Skin Neoplasms - metabolism | Macrophages - metabolism | Phenotype | Animals | Melanoma - immunology | Macrophages - drug effects | Chemokines - metabolism | Angiogenic Proteins - metabolism | Skin - drug effects | Immunologic Factors - therapeutic use | Lymphocytes, Tumor-Infiltrating - immunology | Medical colleges | Immunotherapy | Melanoma | Skin | T cells | Macrophages | Skin cancer
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 01/2018, Volume 8, p. 3
Tumor-associated macrophages (TAMs) and regulatory T cells (Tregs) are significant components of the microenvironment of solid tumors in the majority of...
Immunosuppression | Angiogenetic factors | M2 polarization | Regulatory T cells | Chemokines | Tumor-associated macrophages | LESIONAL SKIN | ANGIOGENESIS | angiogenetic factors | immunosuppression | MYCOSIS-FUNGOIDES | chemokines | CYTOTOXIC-CELLS | tumor-associated macrophages | regulatory T cells | ONCOLOGY | RECEPTOR ACTIVATOR | SUPPRESSOR-CELLS | LIGAND | MELANOMA GROWTH | EXPRESSION | PROMOTES | Care and treatment | Immunotherapy | Innovations | Development and progression | Macrophages | Health aspects | Skin cancer
Immunosuppression | Angiogenetic factors | M2 polarization | Regulatory T cells | Chemokines | Tumor-associated macrophages | LESIONAL SKIN | ANGIOGENESIS | angiogenetic factors | immunosuppression | MYCOSIS-FUNGOIDES | chemokines | CYTOTOXIC-CELLS | tumor-associated macrophages | regulatory T cells | ONCOLOGY | RECEPTOR ACTIVATOR | SUPPRESSOR-CELLS | LIGAND | MELANOMA GROWTH | EXPRESSION | PROMOTES | Care and treatment | Immunotherapy | Innovations | Development and progression | Macrophages | Health aspects | Skin cancer
Journal Article
The Journal of Dermatology, ISSN 0385-2407, 03/2017, Volume 44, Issue 3, pp. e13 - e14
DERMATOLOGY | Skin Neoplasms - pathology | Skin Neoplasms - drug therapy | Enzyme-Linked Immunosorbent Assay | Endocrine System Diseases - chemically induced | Humans | Male | Melanoma - pathology | Nivolumab - adverse effects | Antineoplastic Agents, Immunological - adverse effects | Neoplasm Metastasis | Genetic Diseases, Inborn - chemically induced | Adrenocorticotropic Hormone - deficiency | Melanoma - drug therapy | Aged | Hypoglycemia - chemically induced | ACTH | Melanoma | Metastasis
Journal Article
Experimental Dermatology, ISSN 0906-6705, 12/2017, Volume 26, Issue 12, pp. 1193 - 1198
Pemphigus vulgaris (PV) and bullous pemphigoid (BP) are autoimmune blistering diseases, and substantial numbers of CD163+ tissue‐associated macrophages (TAMs)...
tissue‐associated macrophages | pemphigus | periostin | CXCL5 | IL‐36 | tissue-associated macrophages | IL-36 | RHEUMATOID-ARTHRITIS | M2 MACROPHAGES | CYTOKINES | LESIONAL SKIN | SOLUBLE CD163 | DERMATOLOGY | DISEASE | RECEPTOR ACTIVATOR | EXPRESSION | T-CELLS | PSORIASIS | Interleukin-1 - metabolism | Pemphigus - blood | Dermis - metabolism | Humans | Middle Aged | Receptors, Cell Surface - metabolism | Male | Chemokine CXCL5 - metabolism | Matrix Metalloproteinase 12 - metabolism | Cell Adhesion Molecules - metabolism | Antigens, CD - metabolism | Macrophages - metabolism | Pemphigoid, Bullous - blood | Antigens, Differentiation, Myelomonocytic - metabolism | Aged, 80 and over | Adult | Female | Pemphigus - immunology | Aged | Pemphigoid, Bullous - immunology | Skin | DNA microarrays | T cells | Macrophages | Pemphigus | Bullous pemphigoid | Pemphigoid | Cytokines | Immunomodulation | Dermis | Pemphigus vulgaris | Lymphocytes T | Serum levels | CD163 antigen | Molecular modelling | Skin diseases | Chemokines
tissue‐associated macrophages | pemphigus | periostin | CXCL5 | IL‐36 | tissue-associated macrophages | IL-36 | RHEUMATOID-ARTHRITIS | M2 MACROPHAGES | CYTOKINES | LESIONAL SKIN | SOLUBLE CD163 | DERMATOLOGY | DISEASE | RECEPTOR ACTIVATOR | EXPRESSION | T-CELLS | PSORIASIS | Interleukin-1 - metabolism | Pemphigus - blood | Dermis - metabolism | Humans | Middle Aged | Receptors, Cell Surface - metabolism | Male | Chemokine CXCL5 - metabolism | Matrix Metalloproteinase 12 - metabolism | Cell Adhesion Molecules - metabolism | Antigens, CD - metabolism | Macrophages - metabolism | Pemphigoid, Bullous - blood | Antigens, Differentiation, Myelomonocytic - metabolism | Aged, 80 and over | Adult | Female | Pemphigus - immunology | Aged | Pemphigoid, Bullous - immunology | Skin | DNA microarrays | T cells | Macrophages | Pemphigus | Bullous pemphigoid | Pemphigoid | Cytokines | Immunomodulation | Dermis | Pemphigus vulgaris | Lymphocytes T | Serum levels | CD163 antigen | Molecular modelling | Skin diseases | Chemokines
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 02/2019, Volume 28, Issue 2, pp. 143 - 148
Introduction: Approximately, 30.4-66.0% of cutaneous melanomas possess a mutation in the BRAF gene that activates downstream signaling through the...
BRAF-mutant metastatic melanoma | HDAC inhibitors | BRAF resistance | immune checkpoints inhibitors | BRAF inhibitors | MEK inhibitors | SURVIVAL | MULTICENTER | ADJUVANT DABRAFENIB | OPEN-LABEL | CHEMOTHERAPY | METASTATIC MELANOMA | DABRAFENIB PLUS TRAMETINIB | PI3K | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | VEMURAFENIB | Skin Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Skin Neoplasms - drug therapy | Humans | Melanoma - pathology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Animals | Melanoma - genetics | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Skin Neoplasms - genetics | Protein Kinase Inhibitors - pharmacology | Mutation
BRAF-mutant metastatic melanoma | HDAC inhibitors | BRAF resistance | immune checkpoints inhibitors | BRAF inhibitors | MEK inhibitors | SURVIVAL | MULTICENTER | ADJUVANT DABRAFENIB | OPEN-LABEL | CHEMOTHERAPY | METASTATIC MELANOMA | DABRAFENIB PLUS TRAMETINIB | PI3K | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | VEMURAFENIB | Skin Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Skin Neoplasms - drug therapy | Humans | Melanoma - pathology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Animals | Melanoma - genetics | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Skin Neoplasms - genetics | Protein Kinase Inhibitors - pharmacology | Mutation
Journal Article
The Journal of Dermatology, ISSN 0385-2407, 06/2017, Volume 44, Issue 6, pp. 651 - 655
We report the case of a 42‐year‐old man with a 5‐year history of myelodysplastic syndrome and photosensitivity who had developed painful erythema and blisters...
homozygous IVS3‐48C polymorphism | erythropoietic protoporphyria | myelodysplastic syndrome | photosensitivity | ferrochelatase | homozygous IVS3-48C polymorphism | DIAGNOSIS | CELLS | SIDEROBLASTIC ANEMIA | FEATURES | DELETION | DERMATOLOGY | DERMAL PHOTOSENSITIVITY | PORPHYRIAS ADVANCES | JAPANESE PATIENTS | ERYTHROCYTE PROTOPORPHYRIN | Protoporphyria, Erythropoietic - genetics | Protoporphyria, Erythropoietic - complications | Humans | Age of Onset | Adult | Ferrochelatase - genetics | Male | Photosensitivity Disorders - etiology | Myelodysplastic Syndromes - complications | Genetic research | Genetic aspects | Genes | Genetic polymorphisms | Photosensitivity | Ferrochelatase | Erythrocytes | Blood vessels | Malignancy | Gene polymorphism | Myelodysplastic syndrome | Erythropoietic protoporphyria | Protoporphyrin | Skin | Erythema | Deoxyribonucleic acid--DNA | Porphyrins
homozygous IVS3‐48C polymorphism | erythropoietic protoporphyria | myelodysplastic syndrome | photosensitivity | ferrochelatase | homozygous IVS3-48C polymorphism | DIAGNOSIS | CELLS | SIDEROBLASTIC ANEMIA | FEATURES | DELETION | DERMATOLOGY | DERMAL PHOTOSENSITIVITY | PORPHYRIAS ADVANCES | JAPANESE PATIENTS | ERYTHROCYTE PROTOPORPHYRIN | Protoporphyria, Erythropoietic - genetics | Protoporphyria, Erythropoietic - complications | Humans | Age of Onset | Adult | Ferrochelatase - genetics | Male | Photosensitivity Disorders - etiology | Myelodysplastic Syndromes - complications | Genetic research | Genetic aspects | Genes | Genetic polymorphisms | Photosensitivity | Ferrochelatase | Erythrocytes | Blood vessels | Malignancy | Gene polymorphism | Myelodysplastic syndrome | Erythropoietic protoporphyria | Protoporphyrin | Skin | Erythema | Deoxyribonucleic acid--DNA | Porphyrins
Journal Article
15.
Full Text
Successful control of phototherapy‐resistant lymphomatoid papulosis with oral bexarotene
The Journal of Dermatology, ISSN 0385-2407, 02/2018, Volume 45, Issue 2, pp. e37 - e38
DERMATOLOGY | Skin Neoplasms - pathology | Lymphomatoid Papulosis - pathology | Lymphomatoid Papulosis - therapy | Skin Neoplasms - therapy | Humans | Middle Aged | Female | Treatment Outcome | Antineoplastic Agents - therapeutic use | Bexarotene - therapeutic use | Skin - pathology | Phototherapy | Antimitotic agents | Retinoids | Antineoplastic agents | Lymphomatoid papulosis
Journal Article
Journal of Dermatological Science, ISSN 0923-1811, 2016, Volume 83, Issue 3, pp. 182 - 189
Highlights • We previously reported that the TAMs stimulated by stromal factors produce the chemokines that affect the formation of CTCL. • Since IFN-α and...
Dermatology | IFN-α | Mycosis fungoides | IFN-γ | Tumor-associated macrophages (TAMs) | Chemokines | IMMUNITY | T-CELL LYMPHOMA | SEZARY-SYNDROME | IFN-alpha | DERMATOLOGY | IFN-gamma
Dermatology | IFN-α | Mycosis fungoides | IFN-γ | Tumor-associated macrophages (TAMs) | Chemokines | IMMUNITY | T-CELL LYMPHOMA | SEZARY-SYNDROME | IFN-alpha | DERMATOLOGY | IFN-gamma